A pyrazole curcumin derivative restores membrane homeostasis disrupted after brain trauma.
We have assessed potential mechanisms associated with the deleterious effects of TBI on the integrity of plasma membranes in the hippocampus, together with consequences for behavioral function. In addition, we have investigated the efficacy of a dietary intervention based on a pyrazole curcumin derivative with demonstrated bioactivity and brain absorption, to re-establish membrane integrity. We report that moderate fluid percussion injury (FPI) increases levels of 4-Hydroxynonenal (HNE), an intermediary for the harmful effects of lipid peroxidation on neurons. A more direct action of FPI on membrane homeostasis was evidenced by a reduction in calcium-independent phospholipase A2 (iPLA₂) important for metabolism of membrane phospholipids such as DHA, and an increase in the fatty acid transport protein (FATP) involved in translocation of long-chain fatty acids across the membrane. A potential association between membrane disruption and neuronal function was suggested by reduced levels of the NR2B subunit of the transmembrane NMDA receptor, in association with changes in iPLA2 and syntaxin-3 (STX-3, involved in the action of membrane DHA on synaptic membrane expansion). In addition, changes in iPLA2, 4-HNE, and STX-3 were proportional to reduced performance in a spatial learning task. In turn, the dietary supplementation with the curcumin derivative counteracted all the effects of FPI, effectively restoring parameters of membrane homeostasis. Results show the potential of the curcumin derivative to promote membrane homeostasis following TBI, which may foster a new line of non-invasive therapeutic treatments for TBI patients by endogenous up-regulation of molecules important for neural repair and plasticity.
Sharma
Sandeep
S
Department of Integrative Biology and Physiology, University of California, LA, CA 90095, USA.
Ying
Zhe
Z
Gomez-Pinilla
Fernando
F
D000447:Aldehydes; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D015153:Blotting, Western; D001930:Brain Injuries / Q000188:drug therapy* / Q000473:pathology / Q000523:psychology*; D002462:Cell Membrane / Q000187:drug effects / Q000473:pathology; D003071:Cognition / Q000187:drug effects; D003474:Curcumin / Q000031:analogs & derivatives* / Q000494:pharmacology*; D006706:Homeostasis / Q000187:drug effects*; D007150:Immunohistochemistry; D015227:Lipid Peroxidation / Q000187:drug effects; D008297:Male; D018782:Maze Learning / Q000187:drug effects; D009419:Nerve Tissue Proteins / Q000096:biosynthesis; D009473:Neuronal Plasticity / Q000187:drug effects; D011720:Pyrazoles / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013569:Synapses / Q000187:drug effects
D000447:Aldehydes; D009419:Nerve Tissue Proteins; D011720:Pyrazoles; D003474:Curcumin; C027576:4-hydroxy-2-nonenal
Neurobiol Aging. 2007 Mar;28(3):424-39
16500747
J Neurosci Res. 2010 Jan;88(1):202-13
19658197
J Biol Chem. 1995 Feb 3;270(5):2213-7
7836452
Biol Pharm Bull. 2003 Jun;26(6):787-93
12808287
J Neurotrauma. 2008 May;25(5):527-37
18363507
Neuroreport. 1995 Mar 27;6(5):730-2
7541655
Free Radic Biol Med. 2008 Aug 15;45(4):443-52
18501200
Eur J Pharmacol. 2007 Mar 29;560(1):36-41
17303115
Biochim Biophys Acta. 1999 Oct 18;1441(1):4-13
10526223
Ann Nutr Metab. 1999;43(5):290-300
10749029
Brain Res. 2008 Sep 10;1229:224-32
18640105
Brain Res. 2010 Jun 23;1341:32-40
19446534
J Neurotrauma. 2004 Oct;21(10):1457-67
15672635
Neuroscience. 1997 Oct;80(3):685-96
9276486
Eur J Neurosci. 2005 Aug;22(3):617-26
16101743
Life Sci. 2004 Jan 9;74(8):969-85
14672754
J Neurochem. 1997 Jul;69(1):273-84
9202320
Biochim Biophys Acta. 2006 Nov;1761(11):1246-59
16973413
Neuroscience. 2003;119(2):365-75
12770552
Brain Res Dev Brain Res. 1994 Mar 18;78(1):81-6
7911748
J Neurochem. 2008 May;105(4):1336-45
18208543
Neurochem Res. 2004 Nov;29(11):1961-77
15662832
J Neurochem. 1999 Jun;72(6):2323-33
10349841
Neuroscience. 2009 Jul 21;161(4):1037-44
19393301
Nat Rev Neurosci. 2004 May;5(5):361-72
15100719
Pharmacol Ther. 2003 Jan;97(1):55-85
12493535
Exp Neurol. 2006 Feb;197(2):309-17
16364299
J Biol Chem. 2007 Nov 30;282(48):34611-22
17923475
Prostaglandins Leukot Essent Fatty Acids. 2007 Jan;76(1):47-55
17187973
J Pharmacol Exp Ther. 2008 Jul;326(1):196-208
18417733
Biochim Biophys Acta. 2000 Oct 31;1488(1-2):1-19
11080672
Clin Exp Pharmacol Physiol. 2006 Oct;33(10):934-9
17002670
FEBS Lett. 1995 Dec 27;377(3):358-62
8549755
Neuroscientist. 2006 Jun;12(3):245-60
16684969
Physiology (Bethesda). 2006 Aug;21:259-68
16868315
Learn Mem. 2009 May 27;16(6):395-405
19474217
Behav Neural Biol. 1994 May;61(3):225-32
8067978
J Neurochem. 1998 Dec;71(6):2322-9
9832130
J Neurochem. 2001 Jul;78(2):413-6
11461977
Mech Ageing Dev. 1998 Mar 16;101(1-2):119-28
9593318
Eur J Neurosci. 2006 Jan;23(2):505-13
16420457
Eur J Neurosci. 2004 Apr;19(7):1699-707
15078544
Brain Res. 2001 Jun 15;904(1):13-9
11516407
Neurobiol Aging. 2010 Apr;31(4):706-9
18639368
J Neurosci. 2001 Nov 1;21(21):8370-7
11606625
Neurosci Lett. 2001 Nov 16;314(3):135-8
11704302
Nature. 2006 Apr 6;440(7085):813-7
16598260
Crit Rev Immunol. 1997;17(3-4):225-83
9202883
Curr Pharm Des. 2004;10(18):2177-83
15281893
J Neurochem. 1997 Jan;68(1):255-64
8978733
J Biol Chem. 2005 Feb 18;280(7):5892-901
15590663
J Neurochem. 1997 Sep;69(3):1161-9
9282939